The U.S. Food and Drug Administration (FDA) on Tuesday approved Coagadex for hereditary Factor X (10) deficiency. Read More »

The ‘authorized generic’ version of a drug is an important product consideration for patients, an executive at Sanofi US advised. Read More »

The U.S. Food and Drug Administration (FDA) recently approved Dyanavel XR (amphetamine), extended-release oral suspension, CII, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children six years and older, according to an announcement from Tris Pharma Inc. on Tuesday. Read More »

During Capitol Hill Health Fair on Wednesday, APhA will urge lawmakers to back pharmacy bill Read More »

The American Society of Health-System Pharmacists (ASHP) said Thursday it will hold its first virtual House of Delegates session Nov. 13-20 to give delegates the chance to take early action on ASHP policy recommendations through online discussion and voting. Read More »

President Barack Obama announced a plan Wednesday to combat the nation's drug crisis by boosting training for care providers who prescribe opioids and improving access to treatment facilities for people with addiction. “The drug epidemic this country is facing can only be defeated through collaboration and support from government officials as well as care providers and technology leaders,” Surescripts CEO Tom Skelton said. Read More »

A study conducted by the National Community Pharmacists Association (NCPA) found that independent community pharmacists are able to improve patient health by networking together across diverse practice settings, an article in Pharmacy Times said on Monday. Read More »

Cigna said Monday it recently launched a collaborative care initiative, Cigna Collaborative Care, with the Elliot Physician Network to improve patient access to health care, increase care coordination and achieve improved health, affordability and patient experience in Southern New Hampshire. Read More »

A recent study by the Drug Channels Institute, a leading management educator for and about the pharmaceutical industry, analyzed the highly dynamic prescription drug distribution industry. Read More »

Walgreens announces purchase of Rite Aid in $17.2 billion deal. Read More »

Walgreens Boots Alliance, Inc. and Rite Aid Corp. said Tuesday they have entered into a definitive agreement under which Walgreens will acquire all outstanding shares of Rite Aid.Under the agreement, Walgreens will acquire Rite Aid shares for $9 per share, for a total enterprise value of approximately $17.2 billion. Read More »

The Food and Drug Administration (FDA) has approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, for patients with advanced pancreatic cancer who have been treated previously with gemcitabine-based chemotherapy. Read More »

The Food and Drug Administration (FDA) has expanded the approved uses of Yervoy (ipilimumab) to treat patients with Stage III melanoma. Read More »

International litigation support provider UBIC Inc. has entered into a partnership with M3 Inc. to develop services through artificial intelligence (AI) technology to be used in the health care and pharmaceuticals industries. Read More »

To help Medicare beneficiaries make better choices as they choose drug plans, pending regulatory guidance could increase transparency and accuracy of information on the Medicare Plan Finder website. Read More »

CVS Health's walk-in medical clinic, MinuteClinic, reached a milestone recently with the opening of its 1,000th location on Dupont Circle in Washington, D.C. Read More »

ClearPath Development Co. has partnered with Astellas Pharma Inc. to form a second vaccine company, Nosocomial Vaccine Corp. (NVC). Read More »

The American Society of Health-System Pharmacists (ASHP) recently published its annual compilation, ASHP Best Practices, featuring information such as quality policy positions, statements, guidelines, therapeutic position statements, and therapeutic and clinical practice guidelines for the pharmacy profession. Read More »

PharmaEngine Inc. recently announced the U.S. Food and Drug Administration's (FDA) approval of Merimack's Onivyde (irinotecan liposome injection) in combination with fluorouracil (5-FU) and leucovorin (LV). Read More »

Imlygic (talimogene laherparepvec) has become the first FDA-approved oncolytic virus therapy indicated for the treatment of melanoma lesions in the skin and lymph nodes. Read More »